Published in Int J Radiat Oncol Biol Phys on March 15, 1993
Metabolic alterations: a biomarker for radiation-induced normal brain injury-an MR spectroscopy study. J Magn Reson Imaging (2009) 1.00
Neuroimaging and neuropsychological follow-up study in a pediatric brain tumor patient treated with surgery and radiation. Neurocase (2010) 0.82
Assessing neurotoxicity from the low-dose radiation component of radiosurgery using magnetic resonance spectroscopy. Neuro Oncol (2010) 0.76
Determinants of anisotropic water diffusion in nerves. Magn Reson Med (1994) 3.22
Clinical phase I study of the hypoxic cell radiosensitizer RO-07-0582, a 2-nitroimidazole derivative. Radiology (1977) 2.55
Phase 1 study of high-dose metronidazole: a specific in vivo and in vitro radiosensitizer of hypoxic cells. Radiology (1975) 1.90
Application of continuous relaxation time distributions to the fitting of data from model systems and excised tissue. Magn Reson Med (1991) 1.89
Letter: "High-dose" metronidazole: a preliminary pharmacological study prior to its investigational use in clinical radiotherapy trials. Br J Radiol (1974) 1.87
Changes in water diffusion due to Wallerian degeneration in peripheral nerve. Magn Reson Med (1996) 1.82
Water diffusion in the giant axon of the squid: implications for diffusion-weighted MRI of the nervous system. Magn Reson Med (1994) 1.55
The prepregnancy clinic. Br Med J (1980) 1.42
Peripheral neuropathy related to misonidazole: incidence and pathology. Br J Cancer Suppl (1978) 1.42
The misplace of litigation in medical practice (1998; 38, 365-376) Aust N Z J Obstet Gynaecol (1999) 1.39
Sources of variability in the response of coupled spins to the PRESS sequence and their potential impact on metabolite quantification. Magn Reson Med (1999) 1.37
Binding of 3H-misonidazole to solid human tumors as a measure of tumor hypoxia. Int J Radiat Oncol Biol Phys (1986) 1.32
The neurotoxicity of misonidazole: pooling of data from five centres. Br J Radiol (1978) 1.31
Metabolic and work efficiencies during exercise in Andean natives. J Appl Physiol (1985) (1991) 1.31
A novel technique for measuring human tissue pO2 at the cellular level. Br J Cancer (1986) 1.21
Multi-component T1 relaxation and magnetisation transfer in peripheral nerve. Magn Reson Imaging (1998) 1.16
Response of metabolites with coupled spins to the STEAM sequence. Magn Reson Med (2001) 1.15
Absence of IFNA and IFNB genes from human malignant glioma cell lines and lack of correlation with cellular sensitivity to interferons. Cancer Res (1990) 1.11
Multicomponent water proton transverse relaxation and T2-discriminated water diffusion in myelinated and nonmyelinated nerve. Magn Reson Imaging (1998) 1.11
Proton relaxation studies of water compartmentalization in a model neurological system. Magn Reson Med (1992) 1.11
Single-arm, open-label phase II study of intravenously administered tirapazamine and radiation therapy for glioblastoma multiforme. J Clin Oncol (2000) 1.09
The brain at high altitude: hypometabolism as a defense against chronic hypoxia? J Cereb Blood Flow Metab (1994) 1.09
Radiobiological characterization of the inactivating events produced in mammalian cells by helium and heavy ions. Int J Radiat Oncol Biol Phys (1977) 1.08
Increasing striatal iron content associated with normal aging. Mov Disord (1998) 1.07
RF interference suppression in a cardiac synchronization system operating in a high magnetic field NMR imaging system. Magn Reson Imaging (1989) 1.05
A new multiple quantum filter design procedure for use on strongly coupled spin systems found in vivo: its application to glutamate. Magn Reson Med (1998) 1.02
Basal ganglia iron content in Parkinson's disease measured with magnetic resonance. Mov Disord (1996) 0.98
Non-invasive assessment of human tumour hypoxia with 123I-iodoazomycin arabinoside: preliminary report of a clinical study. Br J Cancer (1992) 0.97
Magnetic resonance spectroscopy of multiple sclerosis: in-vivo detection of myelin breakdown products. Lancet (1993) 0.97
Nuclear magnetic resonance spectroscopy and sensitizer-adduct measurements of photodynamic therapy-induced ischemia in solid tumors. J Natl Cancer Inst (1991) 0.96
The response of the strongly coupled AB system of citrate to typical 1H MRS localization sequences. J Magn Reson B (1995) 0.95
Imaging tumor hypoxia and tumor perfusion. J Nucl Med (1993) 0.94
Development of an in vivo 19F magnetic resonance method for measuring oxygen deficiency in tumors. Magn Reson Med (1991) 0.94
Relaxation times and microstructures. NMR Biomed (2001) 0.93
Radiotherapy pilot trials with sensitizers of hypoxic cells: metronidazole in supratentorial glioblastomas. Br J Radiol (1977) 0.93
Covalent binding of a fluorinated 2-nitroimidazole to EMT-6 tumors in Balb/C mice: detection by F-19 nuclear magnetic resonance at 2.35 T. Int J Radiat Oncol Biol Phys (1986) 0.92
Quantitative characterization of the eddy current fields in a 40-cm bore superconducting magnet. Magn Reson Med (1994) 0.91
Motional degradation of metabolite signal strengths when using STEAM: a correction method. NMR Biomed (1993) 0.91
The application in radiation therapy of substances which modify cellular radiation response. Cancer (1977) 0.91
An in vitro evaluation of the effects of local magnetic-susceptibility-induced gradients on anisotropic water diffusion in nerve. Magn Reson Med (1996) 0.91
Estimation of brainstem neuronal loss in amyotrophic lateral sclerosis with in vivo proton magnetic resonance spectroscopy. Neurology (1998) 0.90
Radiosensitivity testing of human primary brain tumor specimens. Int J Radiat Oncol Biol Phys (1992) 0.90
Yield enhancement of a double-quantum filter sequence designed for the edited detection of GABA. J Magn Reson B (1995) 0.88
Phase I study of corynebacterium parvum in patients with solid tumors. Cancer Chemother Rep (1976) 0.88
High dose misonidazole with dexamethasone rescue: a possible approach to circumvent neurotoxicity. Int J Radiat Oncol Biol Phys (1982) 0.88
Observing N-acetyl aspartate via both its N-acetyl and its strongly coupled aspartate groups in in vivo proton magnetic resonance spectroscopy. J Magn Reson B (1996) 0.88
Relaxation enhancement of the transverse magnetization of water protons in paramagnetic suspensions of red blood cells. Magn Reson Med (1995) 0.87
Comparison of prognostic factors and survival among black patients and white patients treated with irradiation for non-small-cell lung cancer. J Natl Cancer Inst (1992) 0.87
Final report of the phase I trial of the hypoxic cell radiosensitizer SR 2508 (etanidazole) Radiation Therapy Oncology Group 83-03. Int J Radiat Oncol Biol Phys (1990) 0.87
Increased basal ganglia iron in striatonigral degeneration: in vivo estimation with magnetic resonance. Can J Neurol Sci (1998) 0.86
Multiple daily fractionated radiation therapy and misonidazole in the management of malignant astrocytoma. A preliminary report. Cancer (1985) 0.86
Misonidazole combined with hyperfractionation in the management of malignant glioma. Int J Radiat Oncol Biol Phys (1984) 0.86
Hyperfractionated radiation therapy for brain-stem glioma: a phase I-II trial. J Neurosurg (1989) 0.84
Relationship between the neurotoxicity of the hypoxic cell radiosensitizer SR 2508 and the pharmacokinetic profile. Cancer Res (1987) 0.84
Multiexponential proton relaxation in model cellular systems. Magn Reson Med (1991) 0.84
High-dose metronidazole: pharmacokinetics and bioavailability using an iv preparation and application of its use as a radiosensitizer. Cancer Treat Rep (1981) 0.83
Skeletal muscle metabolism and work capacity: a 31P-NMR study of Andean natives and lowlanders. J Appl Physiol (1985) (1991) 0.83
Initial report of the phase I trial of the hypoxic cell radiosensitizer SR-2508. Int J Radiat Oncol Biol Phys (1984) 0.83
Solvent proton relaxation of aqueous solutions of the serum proteins alpha 2-macroglobulin, fibrinogen, and albumin. Biophys J (1990) 0.82
Generalized mitochondrial dysfunction in Parkinson's disease detected by magnetic resonance spectroscopy of muscle. Neurology (1995) 0.82
Eastern Cooperative Oncology Group: a comparison of adjuvant doxorubicin and observation for patients with localized soft tissue sarcoma. J Clin Oncol (1987) 0.82
Cardiovascular adaptations in Andean natives after 6 wk of exposure to sea level. J Appl Physiol (1985) (1991) 0.82
Glutathione levels and chemosensitizing effects of buthionine sulfoximine in human malignant glioma cells. J Neurooncol (1991) 0.82
Residual dipolar coupling of the Cr/PCr methyl resonance in resting human medial gastrocnemius muscle. Magn Reson Med (1999) 0.82
Pharmacokinetic interaction of BCNU and misonidazole in humans. Int J Radiat Oncol Biol Phys (1982) 0.81
Initial pharmacology and toxicology of intravenous desmethylmisonidazole. Int J Radiat Oncol Biol Phys (1982) 0.81
Clinical trials with hypoxic cell sensitizers: time to retrench or time to push forward? Int J Radiat Oncol Biol Phys (1984) 0.81
Cytotoxic and radiosensitizing effects of misonidazole on hematopoiesis in normal and tumor-bearing mice. Int J Radiat Oncol Biol Phys (1980) 0.81
Phase I trial of the hypoxic cell radiosensitizer SR-2508: the results of the five to six week drug schedule. Int J Radiat Oncol Biol Phys (1986) 0.80
Final report on phase I trial of WR-2721 before protracted fractionated radiation therapy. Int J Radiat Oncol Biol Phys (1988) 0.80
31P NMR of electrically stimulated rectus femoris muscle: an in vivo graded exercise model. Magn Reson Med (1992) 0.80
Analysis of the temporal and spatial dependence of the eddy current fields in a 40-cm bore magnet. Magn Reson Med (1992) 0.80
New side effect of the hypoxic cell sensitizer, misonidazole. Cancer Treat Rep (1979) 0.79
In vivo studies of x-irradiation damage and repair in mammalian tumor cells. Radiology (1972) 0.79
Heterogeneity in response to treatment with buthionine sulfoximine or interferon in human malignant glioma cells. Int J Radiat Oncol Biol Phys (1992) 0.79
A proton NMR relaxation evaluation of a model of brain oedema fluid. Phys Med Biol (1986) 0.79
Treatment of infiltrating bladder cancer by cobalt 60 radiation: recurrence of tumor in bladder after initial disappearance. J Urol (1969) 0.79
Hypoxic cell sensitizers and heavy charged-particle radiations. Br J Cancer Suppl (1978) 0.79
Intensity artifacts in MRI caused by gradient switching in an animal-size NMR magnet. Magn Reson Med (1992) 0.79
The modification of the RF field distribution of surface coils by weakly conducting saline samples. Magn Reson Med (1988) 0.79
Proton relaxation in acute and subacute ischemic brain edema. Adv Neurol (1990) 0.78
Estimation of the iron concentration in excised gray matter by means of proton relaxation measurements. Magn Reson Med (1996) 0.78
An (1)H-MRS evaluation of the phosphocreatine/creatine pool (tCr) in human muscle. Am J Physiol Regul Integr Comp Physiol (2001) 0.78
Chronic lithium does not alter human myo-inositol or phosphomonoester concentrations as measured by 1H and 31P MRS. Biol Psychiatry (1996) 0.78
Assessment of temporal changes in pulmonary edema with NMR imaging. J Appl Physiol (1985) (1989) 0.78
Radiation plus metronidazole for glioblastoma. N Engl J Med (1977) 0.78
Estimation of brain iron in vivo by means of the interecho time dependence of image contrast. Magn Reson Med (1996) 0.78
Proton magnetic resonance spectroscopy (1H-MRS) of the cerebellum in men with schizophrenia. J Psychiatry Neurosci (2000) 0.78
An evaluation of the effect of fasting on the exercise-induced changes in pH and Pi/PCr from skeletal muscle. Magn Reson Med (1986) 0.78
Increasing radiation dose intensity using hyperfractionation in patients with malignant glioma. Final report of a prospective phase I-II dose response study. J Neurooncol (1992) 0.77
Fibromyxoma of the mandible: case report and radiographic considerations. J Am Dent Assoc (1980) 0.77
Small-cell lung cancer: initial treatment with sequential hemi-body irradiation VS 3-drug systemic chemotherapy. Br J Cancer (1982) 0.77
In vivo assessment of focal brain lactate alterations with NMR proton spectroscopy. J Cereb Blood Flow Metab (1988) 0.76
Double-quantum filtering of citrate for in vivo observation. J Magn Reson B (1994) 0.76
Comparative effects of castration and dehorning in series or concurrent castration and dehorning procedures on stress responses and production in Holstein calves. J Anim Sci (2013) 0.76
Acute metabolic responses of postpartal dairy cows to subcutaneous glucagon injections, oral glycerol, or both. J Dairy Sci (2008) 0.76
Radiation biophysical studies with mammalian cells and a modulated carbon ion beam. Radiat Res (1978) 0.76
Effect of misonidazole therapy on human granulopoietic stem cells. Cancer Treat Rep (1981) 0.76